Health tech startup Lotus Health has raised US$35 million in a funding round led by CRV and Kleiner Perkins to scale its artificial intelligence–driven care platform that offers medical consultations at no cost to patients.
The company says its AI doctor is licensed to provide care across all 50 U.S. states, making it one of the few generative AI health tools to secure wide regulatory acceptance. The platform uses advanced AI models trained on clinical guidelines, medical literature and real-world data to help users with symptoms, treatment options, medication guidance, preventive care and more. Unlike typical symptom checkers, Lotus Health’s AI doctor is designed to offer interactive consultations and personalised responses that approximate a human clinician’s reasoning.
Investors view Lotus Health as part of a new wave of AI-powered healthcare services aimed at reducing cost barriers and expanding access, particularly where medical professionals are in short supply. Backers like CRV and Kleiner Perkins believe that affordable, scalable digital care tools could ease pressure on traditional healthcare systems and improve outcomes for underserved populations.
The US$35 million round will be used to enhance the platform’s clinical capabilities, strengthen compliance and safety protocols, expand partnerships with healthcare organisations, and accelerate user growth. Lotus Health has emphasised that its AI doctor is intended to complement, not replace, human clinicians; it encourages users to follow up with licensed providers when needed and to use the AI as a preliminary health assessment and guidance tool.
Founders said that regulatory readiness was a priority from the start, aiming to build trust by aligning the system with current medical standards and state licensing requirements. Being licensed in all 50 states positions Lotus Health ahead of many competitors that have faced regulatory scrutiny or limited geographic permissions.
Healthcare and AI experts note that while technology like Lotus Health’s can make basic medical support more accessible, maintaining accuracy, data privacy and clear boundaries around clinical advice will be essential as the sector grows. The company says it has integrated safety checks and oversight mechanisms to mitigate risks and ensure ethical use.
With this funding, Lotus Health joins a broader trend of AI innovation in health tech, where investors are increasingly funneling capital into tools that reduce costs, expand access and reimagine how patients interact with medical information.
Anthropic launches Claude for Healthcare following OpenAI’s ChatGPT Health reveal
